Article Versions Notes

O’Donnell CDJ, Naleid N, Siripoon T, Zablonski KG, Storandt MH, Selfridge JE, Hallemeier CL, Conces ML, Jethwa KR, Bajor DL, et al. Circulating Tumor DNA Predicts Early Recurrence Following Locoregional Therapy for Oligometastatic Colorectal Cancer. Cancers. 2024; 16(13):2407. https://doi.org/10.3390/cancers16132407

O’Donnell, Conor D. J., Nikolas Naleid, Teerada Siripoon, Kevin G. Zablonski, Michael H. Storandt, Jennifer E. Selfridge, Christopher L. Hallemeier, Madison L. Conces, Krishan R. Jethwa, David L. Bajor, and et al. 2024. "Circulating Tumor DNA Predicts Early Recurrence Following Locoregional Therapy for Oligometastatic Colorectal Cancer" Cancers 16, no. 13: 2407. https://doi.org/10.3390/cancers16132407

O’Donnell, C. D. J., Naleid, N., Siripoon, T., Zablonski, K. G., Storandt, M. H., Selfridge, J. E., Hallemeier, C. L., Conces, M. L., Jethwa, K. R., Bajor, D. L., Thiels, C. A., Warner, S. G., Starlinger, P. P., Atwell, T. D., Mitchell, J. L., Mahipal, A., & Jin, Z. (2024). Circulating Tumor DNA Predicts Early Recurrence Following Locoregional Therapy for Oligometastatic Colorectal Cancer. Cancers, 16(13), 2407. https://doi.org/10.3390/cancers16132407